Valisure's CEO, David Light, was invited to speak at the Stanford Medicine Grand Rounds and present the topic, "Drug Quality & Safety Issues in the US and Strategies to Address Them." During his presentation, David had the opportunity to share with top physicians background and extensive data on drug quality issues from Valisure’s numerous petitions and a growing number of studies and reports. Real-world solutions where independent testing, quality scoring, and certification are already being used were also discussed, along with debunking concerns over cost or access if more is done to address quality.

Valisure's CEO, David Light, was invited to speak at the Stanford Medicine Grand Rounds and present the topic, "Drug Quality & Safety Issues in the US and Strategies to Address Them." During his presentation, David had the opportunity to share with top physicians background and extensive data on drug quality issues from Valisure’s numerous petitions and a growing number of studies and reports. Real-world solutions where independent testing, quality scoring, and certification are already being used were also discussed, along with debunking concerns over cost or access if more is done to address quality.